Curi RMB Capital’s abrdn Life Sciences Investors HQL Stock Holding History

Curi RMB Capital’s Portfolio HQL Stock Details HQL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-59,079	Closed	-$1.04M	–	611
2020 Q3	$1.04M	Sell	59,079 -36,938	-38%	-$661K	0.04%	293
2020 Q2	$1.72M	Sell	96,017 -44,934	-32%	-$770K	0.08%	225
2020 Q1	$2.11M	Buy	140,951 +78,008	+124%	+$1.28M	0.1%	194
2019 Q4	$1.1M	Buy	62,943 +27,930	+80%	+$458K	0.03%	349
2019 Q3	$529K	Buy	+35,013	New	+$561K	0.01%	474
2019 Q2	–	Sell	-45,586	Closed	-$781K	–	787
2019 Q1	$781K	Buy	45,586 +4,786	+12%	+$82.6K	0.02%	490
2018 Q4	$616K	Buy	+40,800	New	+$719K	0.02%	590

Other funds holding HQL

Needham Investment Management New York $3.33B AUM 163.16% 1-Year Est. Return

1832 Asset Management Toronto, Ontario, Canada $200B AUM 38.1% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Advisors Asset Management Monument, Colorado $6.56B AUM 35.09% 1-Year Est. Return

Matisse Capital Portland, Oregon $250M AUM 26.81% 1-Year Est. Return

Flagship Harbor Advisors Boston, Massachusetts $2.61B AUM 23.21% 1-Year Est. Return

Cohen & Steers New York $63.2B AUM 17.15% 1-Year Est. Return

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

1607 Capital Partners Richmond, Virginia $1.15B AUM 12.28% 1-Year Est. Return

Curi RMB Capital's HQL Position: Q4 2020 in Review

Curi RMB Capital sold out of abrdn Life Sciences Investors (HQL) in Q4 2020, closing a stake of 59,079 shares — an estimated $1.04M sold.

Curi RMB Capital first reported a position in HQL in Q4 2018 and held it in 7 quarters. The position peaked at $2.11M in Q1 2020. 66 funds tracked by Wall St. Rank hold HQL as of Q4 2020.

Curi RMB Capital reported no remaining abrdn Life Sciences Investors position as of Q4 2020 after selling out during the quarter.
Curi RMB Capital sold 59,079 abrdn Life Sciences Investors shares in Q4 2020, an estimated $1.04M.
Curi RMB Capital first reported a position in abrdn Life Sciences Investors in Q4 2018 and held it in 7 quarters.
Curi RMB Capital's abrdn Life Sciences Investors position peaked at $2.11M in Q1 2020.
66 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q4 2020.

Based on Curi RMB Capital's 13F filing for Q4 2020, filed 11 Feb 2021.